NANTHEALTH, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of December 21, 2016 5.50% Convertible Senior Notes due 2021Indenture • December 21st, 2016 • NantHealth, Inc. • Services-computer processing & data preparation • New York
INDENTURE dated as of December 21, 2016 between NantHealth, Inc., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and U.S. Bank National Association, a national banking association organized under the laws of the United States of America, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
NANTHEALTH, INC. Purchase AgreementNantHealth, Inc. • December 21st, 2016 • Services-computer processing & data preparation • New York
NantHealth, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several initial purchasers listed in Schedule 1 hereto (the “Initial Purchasers”), for whom you are acting as representatives (the “Representatives”), $90,000,000 principal amount of its 5.50% Convertible Senior Notes due 2021 (the “Underwritten Securities”) and, at the option of the Initial Purchasers, up to an additional $15,000,000 principal amount of its 5.50% Convertible Senior Notes due 2021 (the “Option Securities”) if and to the extent that the Initial Purchasers shall have determined to exercise the option to purchase such 5.50% Convertible Senior Notes due 2021 granted to the Initial Purchasers in Section 2 hereof. The Underwritten Securities and the Option Securities are herein referred to as the “Securities”. The Securities will be convertible into cash, shares of common stock of the Company, without par value (the “Common Stock”), or a combination of cash and Common Stock, at the op
PURCHASE AGREEMENTPurchase Agreement • December 21st, 2016 • NantHealth, Inc. • Services-computer processing & data preparation
Cambridge Equities, L.P. (the “Undersigned”), is entering into this Purchase Agreement (the “Agreement”) with NantHealth, Inc. (the “Company”) on December 15, 2016 whereby the Undersigned will purchase (the “Purchase”) the Company’s 5.50% Convertible Senior Notes due 2021 (the “Notes”) having the terms set forth on Exhibit A hereto that will be issued pursuant to the provisions of an Indenture to be dated on or about December 21, 2016 (the “Indenture”) between the Company and U.S. Bank National Association, as Trustee (the “Trustee”).
